TrialClinical and experimental immunology2015

Specificity of human anti-variable heavy (VH ) chain autoantibodies and impact on the design and clinical testing of a VH domain antibody antagonist of tumour necrosis factor-α receptor 1.

J C Cordy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.